Search -

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation TCT 2024

TCT 811: Overweight and Obesity Have the Lowest Mortality Whereas Cachexia Has the Highest Inpatient Mortality Followed by Morbid Obesity in Patients Presenting With ST-Elevation Myocardial Infarction

Presenter: Mohammad Reza Movahed

October 28, 2024

Presentation TCT 2024

TCT 243: Overweight Followed by Obesity and Morbid Obesity Have the Lowest Mortality, Whereas Cachexia Has the Highest Mortality Compared to Normal Weight Category in Patients Undergoing PCI

Presenter: Mohammad Reza Movahed

October 28, 2024

Presentation TCT 2024

TCT 459: Lack of Obesity Paradox Regarding Mortality in Patients Undergoing Extracorporeal Membrane Oxygenation Treatment

Presenter: Mohammad Reza Movahed

October 27, 2024

Presentation TCT 2023

TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial

Presenter: Minju Han

October 25, 2023

News Conference News TCT 2022

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

Todd Neale

September 21, 2022

Presentation TCT 2022

TCT 191: Long-Term Follow-up (12 Years) of STEMI Patients in Accordance to Weight: Does the Obesity Paradox Influence Outcomes in STEMI Survivors?

Presenter: André Luz

September 19, 2022

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

News Opinion Off Script TCT 2018

Off Script: Opacity, Transparency, and Magic Buttons in the Cath Lab

Kwan S. Lee

September 24, 2018

Advertisement

TCT 811: Overweight and Obesity Have the Lowest Mortality Whereas Cachexia Has the Highest Inpatient Mortality Followed by Morbid Obesity in Patients Presenting With ST-Elevation Myocardial Infarction

TCT 243: Overweight Followed by Obesity and Morbid Obesity Have the Lowest Mortality, Whereas Cachexia Has the Highest Mortality Compared to Normal Weight Category in Patients Undergoing PCI

TCT 459: Lack of Obesity Paradox Regarding Mortality in Patients Undergoing Extracorporeal Membrane Oxygenation Treatment

TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

TCT 191: Long-Term Follow-up (12 Years) of STEMI Patients in Accordance to Weight: Does the Obesity Paradox Influence Outcomes in STEMI Survivors?

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Off Script: Opacity, Transparency, and Magic Buttons in the Cath Lab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content